Pédiatrie Sarcomes
CombinaiR3
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Paris
VALERIE LAURENCE
Pédiatrie Tumeurs cérébrales
CDRB436G2201
Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG)
Paris
ISABELLE AERTS
Pédiatrie Tumeurs solides
METRO-PD1-1708
Metro-PD1: a phase I/II trial evaluating anti-PD1 (Nivolumab) in combination with metronomic chemotherapy in children and teenagers with refractory /relapsing solid tumors or lymphoma
Paris
ISABELLE AERTS
Sarcomes
SARCOME 13
Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response)
Paris
SOPHIE PIPERNO-NEUMANN
Pédiatrie Sarcomes
SARCOME 13 (Pédiatrie)
Multicentre, Randomised, Phase 2 Trial of Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients (Metastatic Osteosarcoma at Diagnosis or Localised Disease With Poor Histological Response)
Paris
HELENE PACQUEMENT
Sarcomes
BRF ESS 01
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
Paris
SOPHIE PIPERNO-NEUMANN, SOPHIE PIPERNO-NEUMANN